Accueil>>Signaling Pathways>> Others>>POM 1

POM 1 (Synonyms: Sodium Metatungstate, Sodium Polyoxotungstate)

Catalog No.GC17027

Le POM 1 (polyoxotungstate de sodium) est un puissant inhibiteur de l'ectonucléoside triphosphate diphosphohydrolase (ENTPDase), avec des valeurs de Ki de 2,58 μ ; M, 3,26 μ ; M et 28,8 μ ; M pour la NTPDase 1 (CD 39 et CD39), respectivement.

Products are for research use only. Not for human use. We do not sell to patients.

POM 1 Chemical Structure

Cas No.: 12141-67-2

Taille Prix Stock Qté
50mg
71,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Quality Control Product Documents Related Products

Sodium metatungstate (POM-1) is a potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitor, with Ki values of 2.58 μM, 3.26 μM, and 28.8 μM for NTPDase 1, NTPDase 3 and NTPDase 2 respectively[1]. Sodium metatungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition[2].

References:
[1]. Müller CE, et al. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett. 2006 Dec 1;16(23):5943-7.
[2]. Wall et al. The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition. Neuropharmacology. 2008 Dec;55(7):1251-8.

Avis

Review for POM 1

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for POM 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.